Subscription Required

Only paid subscribers* to Drug Benefit News can access this Web portal with three years of back issues, searchable article archives and other valuable resources.

Subscribers to Drug Benefit News receive

  • 24 biweekly issues of timely news and insightful strategies for reducing costs and improving outcomes, delivered by First Class U.S. Mail and electronically,
  • E-News Alerts whenever important news breaks, and
  • Access to a subscriber-only Web page with:
    • Searchable archives of past articles,
    • Convenient library with PDFs of back issues,
    • Recent stories of interest and hot topic articles grouped for convenient reading, and
    • Regular postings from your editor.
View a sample and get more information
January 6, 2017

Recent Stories

From Drug Benefit News - Health insurers and pharmacy benefit managers participating in the individual health insurance exchanges are facing major challenges as Congress and the incoming Trump administration debate repealing the Affordable Care Act (ACA). Read more

The incoming Trump administration heralds potentially huge changes for the Medicare and… Read more

A Nevada-based limited pharmacy network that originally was launched by two major… Read more

The 21st Century Cures Act, which was signed into law on Dec.… Read more

From the Editor

Welcome to your Drug Benefit News subscriber-only Web page

Be sure to visit often, for PDFs of issues, archives of articles and data, and more!

Please e-mail me with comments on the last issue of Drug Benefit News, story ideas for future issues or any other suggestions you have that can make the newsletter more useful for you.

January 12, 2017
FDA Finalizes Naming Guidance for Biologics, Biosimilars

In final guidance, FDA says all biologics, not only biosimilars, will have four-letter suffixes; agency still considering “appropriate suffix format” for interchangeable biosimilars http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformati...

December 28, 2016
FDA Issues More Biosimilar Guidance

FDA issues guidance on clinical pharmacology data needed to show a product is biosimilar to its reference drug http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformati...

December 2, 2016
CMS Releases 2015 National Health Expenditures Data

CMS reports that spending on prescription drugs rose 9.0% in 2015, down from 12.4% growth in 2014 but an increase from 2.3% in 2013 http://tinyurl.com/j45m46b

Updated Regularly

Featured Hot Topics

Search for your own Hot Topics

It's quick and easy to sign up for FREE access to AISHealth.com!

Why do I need to register?